Date(s) - September 16,2022 - September 18,2022
8:00 am - 1:00 pm
Bally's Las Vegas
HOTEL INFO: please call us to assist with room reservation
Bally’s Las Vegas
group rate $105 Thursday night, $139 Friday night and Saturday nights single or double occupancy. Extra adult in room $30 per night. Max of 4 people in room.
Dr. William Benefield Jr., Pharm D., BCPP, FASCP
University of Texas at San Antonio and Austin
Dr. William Benefield graduated with honors from Auburn University with a BS in Pharmacy and received his Doctorate in Pharmacy degree from the University of Texas at Austin and the University of Texas Health Center at San Antonio. Dr. Benefield completed his residency in Psychiatric Pharmacy Practice at the University of Texas Health Science Center at San Antonio. He has been board certified in Psychiatric Pharmacy since 1997 and is a founding member of CPNP. He is currently a Clinical Assistant Professor of Psychiatry at the University of Texas. He has practiced in the areas of developmental disabilities, hospice and long term care for the past 30 years. He has authored and co-authored chapters in Pharmacotherapy, the Pharmacotherapy Case Book, and Applied Therapeutics. He has presented at the national meetings of the ACCP, ASCP, American Epilepsy Society, American Academy of Neurology, and NCDEU.
Friday, September 16, 2022
SUBSTANCE USE DISORDERS
- Identify signs and symptoms of acute withdrawal, acute intoxication, and chronic dependency associated with alcohol, opiates, and tobacco.
- Describe the pharmacologic and pharmacokinetic properties for therapy used in the treatment of these substance use disorders.
- Apply evidence-based strategies for selecting appropriate pharmacotherapy for a patient with substance use disorder.
- Evaluate the evidence-based literature regarding the treatment of opioid dependence in pregnancy.
- Discuss the management of intrapartum and postpartum pain in opioid dependent patients.
Saturday, September 17, 2022
MOOD DISORDERS PART ONE
- Discuss the classification system and diagnostic criteria for mood disorders found in DSM-5 including Major Depressive Disorder, Bipolar 1 Disorders, and Bipolar 2 Disorder.
- Compare anticonvulsants with regard to treatment, efficacy, side effect profile, and managing adverse reactions.
- Discuss lithium with regard to treatment, efficacy, side effect profile, and managing adverse reactions.
- Compare antipsychotics with regard to pharmacology, treatment, efficacy, side effect profile, and managing adverse effects.
- Compare antidepressants with regard to pharmacology, efficacy, side effect profile, and managing adverse effects.
Sunday, September 18, 2022
MOOD DISORDERS PART TWO
- Compare the various antidepressants with regard to the Cytochrome P-450 drug interaction potential.
- Define Treatment Resistant Depression and discuss treatment strategies including adjunctive medication.
- Identify novel strategies and delivery mechanisms for pharmacologic agents used in the management of mood disorders.
- Identify risk factors associated with the use of antidepressants or anticonvulsants and increased suicidal behavior or ideation.
- Design a treatment regimen with monitoring parameters for a patient with depession or bipolar disorder that includes non-pharmacologic therapy, antipsychotics, antidepressants, mood stabilizers, and/or adjunctive agents.
Don't have a Paypal account?
You do not need a Paypal Account to pay with Paypal. Paypal allows you to pay online simply by entering your credit card and billing information.